Cat. No.: X23-10-ZQ655
CCR antagonist BMS-813160, Purity ≥98%
Synonym: BMS-813160; 1286279-29-5; BMS813160; BMS 813160; BMS 813160 - Bio-X; 83U7957287; N-((1R,2S,5R)-5-((1,1-Dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)-Acetamide; CCR antagonist
- CAS Number: 1286279-29-5
- Compound CID: 51039119
Product Size
2 mg; 5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
BMS-813160, soluble in DMSO and ethanol and insoluble in water, stimulates CCR receptors. The receptors bind to chemokines, which are signaling proteins that direct the migration of immune cells to sites of inflammation, infection, or injury.
Molecular Formula
C25H40N8O2
Solubility
DMSO: 92 mg/mL (189.82 mM); Water: Insoluble; Ethanol: 92 mg/mL (189.82 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-813160 is studied as a CCR2/5 antagonist with potential applications in cancer immunotherapy and fibrosis research.
Related Products
Quick Links